- Release Date: 18/07/24 08:25
- Summary: Phase II/III autism trial shows further benefits
- Price Sensitive: Yes
- Download Document 194.28KB
- Forums
- ASX - By Stock
- Ann: Phase II/III autism trial shows further benefits
NTI
neurotech international limited
Add to My Watchlist
7.14%
!
1.3¢

Ann: Phase II/III autism trial shows further benefits
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.3¢ |
Change
-0.001(7.14%) |
Mkt cap ! $13.64M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $27.65K | 2.126M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 3313977 | 1.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.3¢ | 1011101 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 3313977 | 0.012 |
9 | 2164288 | 0.011 |
7 | 2070000 | 0.010 |
1 | 100000 | 0.009 |
4 | 969000 | 0.008 |
Price($) | Vol. | No. |
---|---|---|
0.013 | 1011101 | 3 |
0.014 | 1875175 | 6 |
0.015 | 365204 | 4 |
0.016 | 495817 | 6 |
0.017 | 362563 | 3 |
Last trade - 13.02pm 04/09/2025 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
TMG
TRIGG MINERALS LIMITED
Jonathan King, Chief Geologist
Jonathan King
Chief Geologist
SPONSORED BY The Market Online